Ingo Hartlapp

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Volker Kunzmann · 8 shared papers, 2013–2026 · strength 1.02
   • Paper Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: … DOI 10.1016/j.esmogo.2025.100274↗
   • Paper Predictive value of computed tomography on surgical resectability in locally advanced pancreatic cancer treated with mu… DOI 10.1016/j.ejrad.2023.110834↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
2. Brigitte Kimmel · 5 shared papers, 2022–2026 · strength 0.84
   • Paper Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: … DOI 10.1016/j.esmogo.2025.100274↗
   • Paper Predictive value of computed tomography on surgical resectability in locally advanced pancreatic cancer treated with mu… DOI 10.1016/j.ejrad.2023.110834↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
3. Friedrich Anger · 5 shared papers, 2022–2026 · strength 0.84
   • Paper Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: … DOI 10.1016/j.esmogo.2025.100274↗
   • Paper Predictive value of computed tomography on surgical resectability in locally advanced pancreatic cancer treated with mu… DOI 10.1016/j.ejrad.2023.110834↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
4. Frank Kullmann · 5 shared papers, 2021–2026 · strength 0.76
   • Paper Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: … DOI 10.1016/j.esmogo.2025.100274↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent… DOI 10.1016/j.esmoop.2024.103705↗
5. Uwe M. Martens · 5 shared papers, 2021–2026 · strength 0.76
   • Paper Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: … DOI 10.1016/j.esmogo.2025.100274↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent… DOI 10.1016/j.esmoop.2024.103705↗
6. Thomas Jens Ettrich · 5 shared papers, 2021–2026 · strength 0.76
   • Paper Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: … DOI 10.1016/j.esmogo.2025.100274↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent… DOI 10.1016/j.esmoop.2024.103705↗
7. Volker Heinemann · 5 shared papers, 2021–2026 · strength 0.76
   • Paper Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: … DOI 10.1016/j.esmogo.2025.100274↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent… DOI 10.1016/j.esmoop.2024.103705↗
8. Jens Thomas Siveke · 5 shared papers, 2021–2026 · strength 0.76
   • Paper Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: … DOI 10.1016/j.esmogo.2025.100274↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent… DOI 10.1016/j.esmoop.2024.103705↗
9. Hana Algül · 5 shared papers, 2021–2026 · strength 0.76
   • Paper Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: … DOI 10.1016/j.esmogo.2025.100274↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
   • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent… DOI 10.1016/j.esmoop.2024.103705↗
10. Stefan Hubert Boeck · 5 shared papers, 2021–2026 · strength 0.76
    • Paper Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: … DOI 10.1016/j.esmogo.2025.100274↗
    • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
    • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent… DOI 10.1016/j.esmoop.2024.103705↗
11. Dirk Waldschmidt · 4 shared papers, 2021–2024 · strength 0.53
    • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
    • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent… DOI 10.1016/j.esmoop.2024.103705↗
    • Paper Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chem… DOI 10.1016/j.esmoop.2022.100552↗
12. Uwe Pelzer · 4 shared papers, 2021–2024 · strength 0.53
    • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagen… DOI 10.1016/j.esmoop.2024.103463↗
    • Paper Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent… DOI 10.1016/j.esmoop.2024.103705↗
    • Paper Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chem… DOI 10.1016/j.esmoop.2022.100552↗
13. Steffen Ormanns · 1 shared paper, 2026 · strength 0.23
    • Paper Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: … DOI 10.1016/j.esmogo.2025.100274↗
14. KV. Guggenberger · 1 shared paper, 2023 · strength 0.17
    • Paper Predictive value of computed tomography on surgical resectability in locally advanced pancreatic cancer treated with mu… DOI 10.1016/j.ejrad.2023.110834↗
15. Ulrich Steger · 2 shared papers, 2013–2014 · strength 0.09
    • Paper Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Loca… DOI 10.1159/000367966↗
    • Paper Complete pathological remission of locally advanced, unresectable pancreatic cancer (LAPC) after intensified neoadjuvan… DOI 10.1159/000348527↗
16. Marcus Bahra · 1 shared paper, 2021 · strength 0.08
    • Paper Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in… DOI 10.1016/s2468-1253(20)30330-7↗
17. Wolfgang Blau · 1 shared paper, 2021 · strength 0.08
    • Paper Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in… DOI 10.1016/s2468-1253(20)30330-7↗
18. Michael Ståhl · 1 shared paper, 2021 · strength 0.08
    • Paper Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in… DOI 10.1016/s2468-1253(20)30330-7↗
19. Ingo Klein · 1 shared paper, 2021 · strength 0.08
    • Paper Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in… DOI 10.1016/s2468-1253(20)30330-7↗
20. Helmut Friess · 1 shared paper, 2021 · strength 0.08
    • Paper Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in… DOI 10.1016/s2468-1253(20)30330-7↗
21. Ken Herrmann · 1 shared paper, 2014 · strength 0.05
    • Paper Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Loca… DOI 10.1159/000367966↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.